StockIQStockIQ.tech

HCA Healthcare Inc. (HCA) Stock Analysis

--

Free AI-powered analysis and research for HCA Healthcare Inc. stock

Sector: Healthcare

HCA snapshot

Data as of 3 Nov 2026 close. Updated daily.

Last close
466.14 USD (-0.34%)
52-week range
353.99 – 556.52
Position in range
55%
1-year change
+1.0%
Market cap (USD)
$97.4B
P/E (trailing)
15.7
RSI (14-day)
56
vs 200-day average
+4.9%
MACD
Below signal line
StockIQ score: 55/100 · Mixed signals

HCA Healthcare Inc. scores 55/100 on StockIQ's model, which reads as mixed signals overall. The price is above its 200-day average and at 55% of its 52-week range, up 1.0% over the past year. Latest reported figures show a profit margin of 8.6% and revenue growth of +3.6%.

What is driving the score
  • RSI Neutral: +5
  • Strong Uptrend: +9
  • MACD Bearish: -8
  • Low Liquidity (0.82 Current Ratio): -10
  • Low P/B (-12.35): +5
  • Above MA200: +4
  • Up Over 1 Year (+1.0%): +3
  • Low Volume (0.3x): -3

Automated, general information only – not financial advice. Scores can be wrong. How the score works

Full HCA report

HCA Healthcare Inc. (HCA) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

Analyze HCA Now โ†’

๐Ÿ“ฐ Latest Update

The 5 most interesting analyst questions from HCA Healthcareโ€™s Q3 earnings call

During HCA Healthcare's Q3 earnings call, analysts posed five key questions focusing on the company's operational efficiency, patient volume trends, and cost management strategies. These inquiries highlight investor concerns regarding HCA's ability to navigate a challenging healthcare environment and maintain profitability. Understanding the company's responses could provide insights into its future performance and growth potential, making this information crucial for investors monitoring the healthcare sector.

Read full article โ†’

History

People also watch

CI
Cigna Group
--
ELV
Elevance Health Inc.
--
CVS
CVS Health Corporation
--
ENSG
The Ensign Group, Inc.
--
ATRC
AtriCure, Inc.
--